GenomeQuest, Inc. Announces Collaboration with Servier to Improve Specificity of Microarray Probes and qPCR Results.Leader in Sequence Search Partners with Leading French Independent Pharmaceutical Company to More Effectively Leverage In-House Data Sources WESTBOROUGH, Mass. -- GenomeQuest, Inc. a leader in sequence search for research and IP, today announced a collaboration with Servier, the leading French independent pharmaceutical company, to seamlessly connect results from high-throughput microarray See micro array. microarray - A technique for performing many DNA experiments in parallel. Nothing to do with computers. experiments to qPCR platforms from different vendors, including Servier proprietary reagent reagent /re·a·gent/ (re-a´jent) a substance used to produce a chemical reaction so as to detect, measure, produce, etc., other substances. re·a·gent n. data sets. As part of the collaboration, Servier provided key scientific insights and guidance to form product requirements while GenomeQuest, Inc. leveraged its many years of expertise in bioinformatics, high-performance computing High-speed computing, which typically refers to supercomputers used in scientific research. , and data management. The collaboration produced a system that optimizes experimental study design and analysis by providing a simple way to view and analyze the exhaustive set of transcripts and biological assays for a gene. The deliverables of the collaboration to Servier include highly maintainable gene catalogs for human, mouse, and rat and a companion visualization Using the computer to convert data into picture form. The most basic visualization is that of turning transaction data and summary information into charts and graphs. Visualization is used in computer-aided design (CAD) to render screen images into 3D models that can be viewed from all module that integrates all Servier proprietary content with public and vendor reagent libraries. In turn, GenomeQuest, Inc. has retained the right to commercialize the software and know-how to help other companies with a similar requirement integrate their own proprietary data sets. Emmanuel Canet, M.D. Ph.D, Vice President of Research and Development of Servier, said, "We chose to work with GenomeQuest, Inc. because we have a long track record of successful innovations working with Jean-Jacques Codani PhD. and his team on a range of bioinformatics projects over many years. More importantly, we could see that GenomeQuest, Inc. management had a vision for how to commercialize the results of our collaboration. This set the stage for a true win-win partnership. Servier gains early access to the technology and GenomeQuest is able to leverage the investment for the long-term." Ronald Ranauro, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of GenomeQuest, Inc., said, "It is GenomeQuest's privilege to work closely with Servier and gain access to their scientific team to leverage their scientific insights into our long-term product strategy." About Servier Servier is the leading independent French pharmaceutical company, established in 1954 by its founder, Jacques Servier, M.D., Pharm.D. The group is established in 140 countries and 82% of Servier products are prescribed out of France. Sales turnover in 2006 rose to 3.3 billion euros. Almost 25% of Servier's turnover is invested in research and development. The Servier Group counts 16 Internationals Centers of Therapeutic Research, and its principal therapeutic research orientations are cardiovascular diseases Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease , diabetes, neuropsychiatric neu·ro·psy·chi·a·try n. The medical study of disorders with both neurological and psychiatric features. neu disorders, cancer, and osteoarticular diseases. More information is available at: www.servier.com. About GenomeQuest, Inc. GenomeQuest, Inc. is a leader in biological sequence search, content and analysis. Backed by an automatically-updated database that includes over 137 million sequence records, the company's flagship product A primary product of a company, which is typically why the company was founded and/or what made it well known. For example, MS-DOS, Windows and the Microsoft Office suite have been flagship products of Microsoft. CorelDRAW is a flagship product of Corel Corporation. , GenomeQuest[TM] 4.0, is a Web-based search and analysis application that provides scientists and IP professionals with one source for the most comprehensive, accurate and complete sequence information available. Leading life sciences companies and IP law firms This list of the world's largest law firms by revenue is taken from The Lawyer and The American Lawyer and is ordered by 2006 revenue:[1]
GenomeQuest, Inc., is headquartered in Westborough, Massachusetts For other uses of "Westborough", see Westborough (disambiguation).
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion